The pharmaceutical solvents market is capturing a valuation of US$ 3.9 billion in 2023 and is predicted to reach US$ 6.1 billion by 2033. The market is registering a CAGR of 4.6% during the forecast period.
Several Factors Influence the Global Market are:
Increasing Green Chemistry and Innovation to Boost Pharmaceutical Solvents Sales
Due to the rising wastage and the high cost of pharmaceutical solvents, key manufacturers are investing in green chemical processes. It helps to minimize wastage and boost sales.
The regulatory authorities are improving the green chemical processes to encourage the leading players to adopt these strategies. For instance, the United States Environmental Protection Agency (EPA) acknowledged the need for green chemical processes. It helps to reduce the emission of toxic chemicals used in drug formulation.
With the adoption of green chemical processes, the pharmaceutical industry is projected to save millions in manufacturing costs. Adopting these processes can efficiently reduce the hazardous effect and use eco-friendly drug solvents.
The rising demand for novel drug delivery development systems such as inhalation, transdermal patches, and implants drives the market growth. The popularity of natural solvents is increasing due to concern over environmental impacts. The growing advanced technology, such as nanotechnology is expected to boost the market size.
Increase Usage of Residual Solvents and Toxic Chemicals. Decline the Market Growth
The pharmaceutical industry is witnessing significant investments in developing medical and drug delivery systems. These solvents are increasingly being used for the formulation of drugs and vaccines.
The emission of toxic chemicals and residual solvents is negatively impacting the environment. Hence, regulatory bodies imposed stringent regulations surrounding the toxicity of used solvents.
Manufacturers are investing extensively to develop green chemical processes to reduce the number of solvents used and their toxicity. It is expected to create opportunities for key players working for green solvents. The fluctuations in raw material prices and adopting alternate technologies limit market growth.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 4.6% |
| Market Valuation (2023) | US$ 3.9 billion |
| Market Valuation (2033) | US$ 6.1 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market was valued at US$ 3 billion in 2018 and is anticipated to reach US$ 3.7 billion in 2022. The market stood at a CAGR of 4.2% between 2018 and 2022.
As per Future Market Insights (FMI), the demand for pharmaceutical solvents across the globe is projected to increase by 1.5x, registering healthy growth. The overall sales in the market are projected to witness a sharp inclination with ongoing development in the healthcare infrastructure.
Growing investments for new drug delivery systems and increasing demand for fresh medicines and vaccines are fueling the demand for pharmaceutical solvents. Pharmaceutical solvents are extensively used in the manufacturing of drugs and vaccines by dissolving other compounds.
The manufacturers are enhancing the pharmaceutical sector by playing a crucial role in developing quality, drug formulation, and delivery. The increasing demand for pharmaceuticals and growing advanced technologies fuel the global market. These factors are anticipated to drive the market growth.
Asia Pacific is one of the significant nations in the global market, rapidly capturing huge growth. The increasing huge investments the government supports, and rising awareness are advancing the market growth. The growing urbanization, population, technological advancements, and increasing economies are predicted to drive market growth.
Based on the chemical group, alcohols are estimated to hold the maximum share of 29.0% in the global market. However, the demand for alcohol is gaining immense traction in the pharmaceutical industry. The rising ability to dissolve polar compounds rapidly increases the adoption of alcohols-other chemical groups such as ethers, hydrocarbons, and esters.
The adoption of solvents such as methanol, acetone, ethyl acetate, and ethanol is increasing for high-quality tablet coatings. However, demand for alcohol-based pharmaceutical solvents is set to gain traction with growing sales of ethanol and isopropanol. Water is highly used for low toxicity, and better availability is fueling the market growth.
Principal Consultant
| Countries | Projected Share |
|---|---|
| United States | 20.9% |
| Germany | 6.4% |
| Japan | 6.1% |
| Australia | 0.8% |
| China | 5.3% |
| India | 5.7% |
| United Kingdom | 3.3% |
The United States is anticipated to dominate by capturing 20.9% of the global market during the forecast period. The rising demand for pharmaceutical solvents is due to the growing generic population and the rising prevalence of chronic diseases in the country. The manufacturers are innovating new drug development with advanced nanotechnology and are expanding the market size.
The Food & Drug Administration in the United States set various regulation guidelines to limit the use of residual solvents in manufacturing processes. The government promotes green and sustainable manufacturing processes, which is estimated to boom the pharmaceutical sector in the country. The green solvents are environment-friendly and reduce toxicity levels while manufacturing. These factors are crucial to the upsurge of the United States pharmaceutical solvent market.
As per Future Market Insights, the United Kingdom accounted for 3.3% of the global market during the forecast period. The increasing number of pharmaceutical companies and innovative new drug discoveries fuel the United Kingdom market.
Rising well-established supply chains and logistics are aiding the growth of the United Kingdom pharmaceutical solvents market. The rising awareness regarding the benefits of pharmaceutical drugs and increasing demand for solvents for vaccines are uplifting the market in the country.
Increasing Application of Pharmaceutical Solvents in the Food & Beverage Sector to Propel Demand
China is estimated to capture a share of 5.3% of the global market during the forecast period. According to the study, China, the USA, and Germany, collectively accounted for 38% share in 2022. With China holding the major share, the demand for pharmaceutical solvents is expected to rise in East Asia.
The presence of leading pharmaceutical companies and their dependence on active pharmaceutical ingredients (API) and solvents will fuel the demand in China. Also, the increasing use of pharmaceutical solvents in the food and beverages industry is surging China's pharmaceutical solvents market.
India is significantly growing the global market by securing a share of 5.7% with the rising number of market players. Leading pharmaceutical companies such as Pfizer, Novartis, and others are increasing the adoption of green chemical processes for drug formulations.
As per the India Brand Equity Foundation, India is the world's third-largest pharmaceutical manufacturer. The government of India imposes stringent regulations to reduce the toxicity of solvents.
The country promotes natural solvents to increase the need for eco-friendly drug formulations. It is expected to create a conducive environment for the Indian pharmaceutical solvents market.
Manufacturers can expand the global market through their several marketing strategies, including:
These are a few strategies manufacturers adopt to expand the global pharmaceutical solvent market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The number of essential players highly fragments the market. These players play a vital role in expanding the global market through innovations, new product launches, and research and development activities. The companies offer a wide range of eco-friendly solvents to reduce carbon footprints. They develop strong bonds with their consumers to satisfy their needs.
They are developing improved, efficient, customized, and safe products through advanced technologies. The key players adopt various marketing strategies to uplift the market, including mergers, acquisitions, partnerships, agreements, collaborations, and product launches.
Other Key Players in the Global Market are:
Recent Developments in the Global Market are:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Chemical Group, Region |
| Key Companies Profiled | ExxonMobil Corporation; Royal Dutch Shell PLC; Yip’s Chemical Holdings Limited; Mitsubishi Chemical Corporation; Merck KGaA; Avantor, Inc; BASF SE; Sigma-Aldrich Co. LLC; Dow Inc; Thermo Fisher Scientific Inc; Ashland Global Holdings Inc; Honeywell International Inc; Eastman Chemical Company |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market will expand at a 4.6% CAGR through 2033.
The market is valued at US$ 3.9 billion in 2023.
The market will reach US$ 6.1 billion by 2033.
From 2018 to 2022, the global market exhibited 4.2% CAGR.
The United States will hold 20.9% of the market share in 2023.
1. Executive Summary | Pharmaceutical Solvents Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Billion) & Volume (Tonnes) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Billion) & Volume (Tonnes) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Chemical Group
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Billion) & Volume (Tonnes) Analysis By Chemical Group, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Billion) & Volume (Tonnes) Analysis and Forecast By Chemical Group, 2023 to 2033
5.3.1. Alcohol
5.3.1.1. Ethanol
5.3.1.2. Isopropanol
5.3.1.3. Propanol
5.3.1.4. Propylene Glycol
5.3.2. Amine
5.3.2.1. Aniline
5.3.2.2. Diphenylamine
5.3.2.3. Methylethanolamine
5.3.2.4. Trimethylamine
5.3.3. Ester
5.3.3.1. Acetyl Acetate
5.3.3.2. Ethyl Acetate
5.3.3.3. Butyl Acetate
5.3.4. Ether
5.3.4.1. Diethyl Ether
5.3.4.2. Anisole
5.3.4.3. Polyethylene Glycol
5.3.5. Chlorinated Solvents
5.3.5.1. Carbon Tetrachloride
5.3.5.2. Dichloromethane
5.3.6. Others
5.4. Y-o-Y Growth Trend Analysis By Chemical Group, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Chemical Group, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Billion) & Volume (Tonnes) Analysis By Region, 2018 to 2022
6.3. Current Market Size Value (US$ Billion) & Volume (Tonnes) Analysis and Forecast By Region, 2023 to 2033
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. MEA
6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
7.1. Historical Market Size Value (US$ Billion) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022
7.2. Market Size Value (US$ Billion) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033
7.2.1. By Country
7.2.1.1. The USA
7.2.1.2. Canada
7.2.2. By Chemical Group
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Chemical Group
7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Billion) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Billion) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Chemical Group
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Chemical Group
8.4. Key Takeaways
9. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Billion) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Billion) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. United Kingdom
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Chemical Group
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Chemical Group
9.4. Key Takeaways
10. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Billion) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Billion) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Chemical Group
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Chemical Group
10.4. Key Takeaways
11. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Billion) & Volume (Tonnes) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Billion) & Volume (Tonnes) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Chemical Group
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Chemical Group
11.4. Key Takeaways
12. Key Countries Market Analysis
12.1. Value (US$ Billion) & Volume (Tonnes)ed States
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2022
12.1.2.1. By Chemical Group
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2022
12.2.2.1. By Chemical Group
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2022
12.3.2.1. By Chemical Group
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2022
12.4.2.1. By Chemical Group
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2022
12.5.2.1. By Chemical Group
12.6. United Kingdom
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2022
12.6.2.1. By Chemical Group
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2022
12.7.2.1. By Chemical Group
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2022
12.8.2.1. By Chemical Group
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2022
12.9.2.1. By Chemical Group
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2022
12.10.2.1. By Chemical Group
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2022
12.11.2.1. By Chemical Group
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2022
12.12.2.1. By Chemical Group
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2022
12.13.2.1. By Chemical Group
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2022
12.14.2.1. By Chemical Group
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2022
12.15.2.1. By Chemical Group
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2022
12.16.2.1. By Chemical Group
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2022
12.17.2.1. By Chemical Group
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2022
12.18.2.1. By Chemical Group
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2022
12.19.2.1. By Chemical Group
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Chemical Group
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. BASF SE
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.1.5.2. Product Strategy
14.1.1.5.3. Channel Strategy
14.1.2. The Dow Chemical Company
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.2.5.2. Product Strategy
14.1.2.5.3. Channel Strategy
14.1.3. ExxonMobil Corporation
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.3.5.2. Product Strategy
14.1.3.5.3. Channel Strategy
14.1.4. Royal Dutch Shell PLC
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.4.5.2. Product Strategy
14.1.4.5.3. Channel Strategy
14.1.5. Yip’s Chemical Holdings Limited
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.5.5.2. Product Strategy
14.1.5.5.3. Channel Strategy
14.1.6. Mitsubishi Chemical Corporation
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.6.5.2. Product Strategy
14.1.6.5.3. Channel Strategy
14.1.7. Eastman Chemical Company
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.7.5.2. Product Strategy
14.1.7.5.3. Channel Strategy
14.1.8. Clariant AG
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.8.5.2. Product Strategy
14.1.8.5.3. Channel Strategy
14.1.9. Merck KGaA
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.9.5.2. Product Strategy
14.1.9.5.3. Channel Strategy
14.1.10. Procter & Gamble
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
14.1.10.5.2. Product Strategy
14.1.10.5.3. Channel Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
Explore Chemicals & Materials Insights
View Reports
Pharmaceutical Solvents Market
